Načítá se...
In Vitro Susceptibility Testing of Tedizolid against Nontuberculous Mycobacteria
Tedizolid is a new oxazolidinone with improved in vitro and intracellular potency against Mycobacterium tuberculosis, including multidrug-resistant strains, and some species of nontuberculous mycobacteria (NTM) compared with that of linezolid. Using the current Clinical and Laboratory Standards Inst...
Uloženo v:
| Vydáno v: | J Clin Microbiol |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
American Society for Microbiology
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5442531/ https://ncbi.nlm.nih.gov/pubmed/28330892 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JCM.00274-17 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|